Table of Contents (TOC)
David Allen, CU Associate Vice President for Technology Transfer
David Allen, Kate Tallman, Rick Silva, Tom Smerdon: Report TTO 2007-08 Metrics (3 parts)
Dr. Stephanie J. Bryant, New Inventor of the Year, Boulder
Dr. Paul A. Bunn, Inventor of the Year, Denver
Dr. Douglas L. Gin, Inventor of the Year, Boulder
Dr. Lia Gore & Dr. Deborah DeRyckere, New Inventors of the Year, Denver
Dr. Jeremy Haefner, Associate Vice Chancellor for Research and Innovation, Dean, Graduate School Dean, College of Engineering and Applied Science, Director CITTI, University of Colorado at CO Springs
David Hiller & Carl Koval 1 of 2, Center for Revolutionary Solar Photo Conversion (and Part 2 of 2)
Dr. Michael Larson, New Inventor of the Year, CO Springs
Paul A. Nelson and Kate Tallman Energy Initiative Leadership Council
Drs. Woodruff Emlen and V. Michael Holers Taligen Technologies, Inc.
Dr. Stein Sture, Vice Chancellor for Research and Dean of the Graduate School, Boulder
Dr. Richard Traystman, Vice Chancellor for Research, Professor in Pharmacology, UCDHSC
HB1001 Economic Development Stimulated
David Allen, CU TTO; Denise Brown, CBSA; Dr. Richard Duke

University of Colorado's Office of Technology Transfer Mission Statement
The mission of the CU Technology Transfer Office is to aggressively pursue, protect, package, and license to business the intellectual property generated from the research enterprise and to serve faculty, staff, and students seeking to create such intellectual property.
(303) 735-3711 - Email: techtransfer@cu.edu - http://www.cu.edu/techtransfer

407_ The University of Colorado Research Community
CU Associate Vice President for Technology Transfer David Allen explains to Larry Nelson how the CU Research Community works with leaders at all three CU Universities. This is part of a three-part series and will include interviews with Dr. Stein Sture, Vice Chancellor for Research and Dean of the Graduate School, CU-Boulder, Dr. Richard Traystman, Vice Chancellor for Research, UCDHSC, and Dr. Jeremy Haefner, Associate Vice Chancellor for Research and Innovation and Dean of the Graduate School (and Dean of the College of Engineering and Applied Sciences). David points out these research teams are one of the primary reasons why the University of Colorado has such high national rankings even though their budget doesn't touch the universities on the east and west coast. The synergy between the CU Research Community and the CU Technology Transfer Office has a tremendous 'economic development' for the state of Colorado. Listen to how it's done.
Related Links:  CU TTO Channel || CU TTO Winners || CU Tech Transfer Office || Award Photos || Keywords:David Allen, Technology Transfer, CU, University of Colorado, Research Community, Economic Development, Colorado> Bytes: 12419555 > 11/12/07> Return to TOC

DENVER, Colo. (January 14, 2008) – The University of Colorado’s Technology Transfer Office, ranked eighth nationally for the number of companies created and 11th for gross revenue, presented its annual awards January 14 to researchers working in areas ranging from leukemia treatments to lasers in homeland security applications, and to companies supporting innovation. The awards event, held at the historic Tivoli Turnhalle, was attended by more than 200 local business leaders and faculty inventors. Following a talk by Colorado Governor Bill Ritter, awards were presented to inventors, companies and others who demonstrate best practices in technology transfer. Awards were given to:

Dr. Michael Larson, New Inventor of the Year, Colorado Springs. Professor of Mechanical and Aerospace Engineering, and El Pomar Endowed Chair of Engineering and Innovation. Current research focus is on laser/materials interactions, especially related to medical and homeland security applications.

Dr. Lia Gore & Dr. Deborah DeRyckere, New Inventors of the Year, Denver. Respectively, Assistant Professor and Research Instructor of Pediatrics, Section of Hematology, Oncology and Bone Marrow Transplantation. Research is focused on treating cancers and leukemias using a variety of compound combinations.

Dr. Stephanie J. Bryant, New Inventor of the Year, Boulder. Assistant Professor of Chemical and Biological Engineering. Research interests revolve around functional tissue engineering, photopolymerization, and biomaterials.

Dr. Paul A. Bunn, Inventor of the Year, Denver. Director of the University of Colorado Cancer Center, and James Dudley Endowed Chair of Lung Cancer Research. Research interests include novel therapies in non-small cell and small cell lung cancer.

Dr. Douglas L. Gin, Inventor of the Year, Boulder. Professor of Chemical and Biological Engineering and of Chemistry and Biochemistry. Research group is applying organic synthesis and molecular design to the construction of functional nanostructured materials.

Dan Mitchell, Bioscience Business Advisor of the Year. Founding partner, Sequel Venture Partners. Honored for his leadership in university bioscience start-up company financing, his involvement as a reviewer and evaluator of University bioscience IP, and his help as a mentor for biotech entrepreneurs. 

Paul Nelson, Physical Science/Engineering/IT Business Advisor of the Year. Renewable energy entrepreneur. Honored for his efforts building University/Industry partnerships in the renewable energy space.

ColorLink, Inc., Physical Sciences/Engineering/IT Company of the Year. ColorLink, formed in 1995 to develop and commercialize research conducted at CU-Boulder, is one of the world’s leading inventors and suppliers of photonics-based solutions. Current focus is on polarization control   solutions for customer-defined performance and cost requirements. The company’s products are now being utilized in demanding polarization applications including consumer electronics, medical diagnostics, avionics and photography. In March 2007 ColorLink Corporation was acquired by REAL D, a world leader in digital 3-D technology.

BaroFold, Inc., Bioscience Company of the Year. BaroFold is a venture backed Boulder-based biopharmaceutical company focused on developing improved biopharmaceuticals for patients suffering from chronic immunologic and auto-immune disorders. The company’s goal is to discover, develop and commercialize protein biologics incorporating its proprietary PreEMT™ high pressure folding technology (a patented technology invented by CU founders Ted Randolph and John Carpenter), along with other state-of-the-art technologies. Since its inception in 2003, the company has leveraged its unique technology to generate licensing agreements with several biopharmaceutical companies, including Genentech, Pfizer, Eli Lilly and, most recently, Avecia Biologics. In May 2007 the company closed a Series A institutional financing round raising $12M.

Dr. Myron J. Levin, Inductee into the Pinnacles of Inventorship. Professor of Pediatrics and Medicine at UC Denver. Dr. Levin was a member of the Harvard Medical School faculty for over ten years, as well as Chief of the Division of Clinical Microbiology at the Sidney Farber (now Dana Farber) Cancer Institute, before joining the faculty of the CU School of Medicine and The Children's Hospital in 1982. Dr. Levin's major research interests include prevention of varicella or herpes zoster with live attenuated varicella vaccines; mechanism of latency of varicella-zoster virus; mechanism and efficacy of antiviral agents; and  immune response to vaccines, with emphasis on herpes viruses. Dr. Levin’s shingles vaccine, Zostavax, was approved by the FDA in 2006 and is marketed by Merck & Co. Recently, he was given a Lifetime Achievement Award from the Varicella-Zoster Research Foundation.

Dr. John M. Stewart, Inductee into the Pinnacles of Inventorship. Professor of Biochemistry and Molecular Genetics at UC Denver. Dr. Stewart has authored nearly 400 peer-reviewed papers, and is an inventor on 23 patents. His research revolves around the chemistry and biology of peptides, and enabled the design and construction of the world’s first automated peptide synthesizer. A current research focus is the development of more potent bradykinin antagonists, and application of them to the pathophysiology of inflammation and cancer. Dr. Stewart has served on the faculty of the School of Medicine since 1968.

About the Technology Transfer Office
The CU Technology Transfer Office pursues, protects, packages, and licenses to business the intellectual property generated from research at CU. The TTO provides assistance to faculty, staff, and students, as well as to businesses looking to license or invest in CU technology. For more information about technology transfer at CU, visit www.cu.edu/techtransfer.

About the University of Colorado
The University of Colorado is a three-campus system with campuses in Boulder and Colorado Springs, and a Denver campus located in downtown Denver and at the Anschutz Medical Campus in Aurora. CU is a premier teaching and research university, ranked sixth among public institutions in federal research expenditures by the National Science Foundation. Academic prestige is marked by CU’s four Nobel laureates, seven Mac Arthur “genius” Fellows, 18 astronauts, 19 Rhodes Scholars and CU-Boulder’s ranking of 11th best public university in the world by the Institute for Higher Education. For further information, please visit https://www.cu.edu.

433_ Innovation, Economic Development and the University
Higher education plays an important role in economic development and retaining global competitiveness of the United States. "My focus is on innovation and how to guide a campus of our size towards a culture of innovation explains," Dr. Jeremy Haefner, Associate Vice Chancellor for Research and Innovation, Dean, Graduate School Dean, College of Engineering and Applied Science, Director CITTI, University of Colorado at Colorado Springs. UCCS is an important part of the CU Tech Transfer Organization effort and plays heavily on its Innovation focus. Dr. Haefner is very encouraged about the UCCS 'Mind Studio' (making prototypes, their 'emerging venture micro funds' their focus on 'security' as well as the partnerships and other areas they are developing. There is a great deal more...listen now...

Related Links: UCCS || CU TTO Channel || CU Tech Transfer Office || Tech Transfer Awards || Awards Banquet Photos || Keywords: Jeremy Haefner, CUTTO, UCCS, CITTI, Innovation, Tech Transfer > Bytes: 29056839 - 2/4/08 Return to TOC

444_ Imagination, Innovation, Invention: Your Ultimate Expression
Imagine tackling the problem of making cavities or pores that are one nanometer or smaller so that we could do things to molecules on the same size and scale on which they exist. Dr. Douglas Gin, Professor of Chemical and Biological Engineering at the University of Colorado and the Gin Research Group actually made membranes with uniform pore sizes that are less than 1 nanometer, to do things like clean salt out of water, to clean small molecules, contaminants out of water – and even to remove really small molecules, toxic chemical warfare agents out of the air, but to still allow water, vapor or sweat to go through in a very, very selective fashion. Doug said, "What I think is really great is working with people like Dave Allen and the people at CU TTO. They’ve really wanted us to pursue this work and they’ve been very supportive in getting these ideas patented and getting them to the right people to begin evaluating them for real commercial applications. It took coming to Colorado to work with the Chemistry Department and the Chemical Engineering Department as well as working with some local startup companies and technology development companies in the Colorado area that allowed me to do, what I considered the ultimate expression of what we tried to do with our nano force material over a decade ago. 2/18/08  LISTEN
Related Links: Gin Research Group || CU TTO Award Photos || CU TTO Channel || CU Tech Transfer Office || Nanofiltration Membrane   Keywords: Douglas Gin, Nano, CU, Tech Transfer, Gin Research Group, David Allen, Nanofiltration > Bytes: 18650491 Return to TOC

438_ Economic Development a Key to Making Important Decisions
He came from New Orleans with the Katrina refugees, after spending some time in Boston as a visiting professor at MIT, he landed here in Colorado just after co-founding a couple companies. Dr. Michael Larson, Professor of mechanical & aeronautic engineering and El Pomar Chair of Engineering and Innovation had many choices before deciding to come to CITTI. Before taking the position, with his desire to develop ideas that he would come up with, but also to help others do the same, it was very important to him that if he was at a university, the Tech Transfer office would take a very progressive view toward stimulating that kind of activity among the faculty. Michael talked with David Allen and many of his staff and found that really is the case. He appreciated the help they are giving him now and also just their general attitude toward economic development role that the university can play. Dr. Larson was awarded the New Inventor of the year, Colorado Springs Award by CU TTO. There are many facinating ideas for economic development in this interview and Mind Studios is one of them. 2/11/08 
Related Links: UCCS: Engineering & Applied Science || Mind Studios || CU TTO Award Photos || CU TTO Channel || CU Tech Transfer Office   Keywords: Michael Larson, UCCS, Mind Studios, Mothers of Invention, CUTTO > Bytes: 19514830 Return to TOC

441_ Teaming Up, Pooling Resources Leads to a Creative Solution
We were looking at how we could build this device and this bio reactor. Our original idea was to purchase a device from a company and then modify it to fit our needs. In the process of doing that we realized it would cost us over $100,000. It had way more capabilities than we needed. So that led us to think about building our own bio reactor and how could we do this. I actually had a team working on this and we came up with a design that enabled us to apply these mechanical forces in the least expensive way. So we got together, came up with the idea, built it and are actually growing cartilage. This was done by Dr. Stephanie Bryant's team at CU in Boulder. She was given the New Inventor of the Year Boulder designation, at the recent CU TTO Awards banquet. Stephanie went onto point out her greatest lesson learned. Working with a group from different backgrounds. I think that not one of us could have come up with the invention on our own, but by teaming up and pooling our resources we were able to come up with a creative solution that allows us to patent it. Without the team I don’t think we would have been able to come up with that. Listen now... Related Links: CU TTO Award Photos || CU TTO Channel || CU Tech Transfer Office || Find It || Keywords: Stephanie Bryant, CU TTO, Team, Cartilage, Chemical, Biological Engineering > Bytes: 29056839
Return to TOC

576_ Energy Initiative Leadership Council: Business and Education
"We definitely need a connection to the business community for the academic research that goes on, so that the business community can hear what is going on and we can understand in the academic world, what some of the leading trends are," said Kate Tallman, Director of the CU Tech Transfer Office Boulder and Colorado Springs. Kate and CU TTO's guest, Paul Nelson who is focused on Special Projects for the Energy Initiative Leadership Council (EILC) discuss the goals of EILC as well as how they will help support the Colorado energy sector and Colorado's position as the epicenter of the clean tech energy scene. Paul said, "Kate, and myself along with Dave Allen at Tech Transfer; Paul Jerde at the Deming Center for Entrepreneurship and Dr. Carl Koval who is heading up the Energy Initiative, put our heads together and thought about how we could more effectively bring in the private sector to the Energy Initiative." He went onto say, ". So the idea was to form this council that provides guidance. The thinking was that each seat on the council would represent a unique perspective on the issue. We have some from the financial community; we wanted the venture capital and investment fund and individual investor and banking perspectives. But we have another group of seats that are more traditional industry; we have an automotive seat and materials seat and things like that. Then we have a group of seats that are traditional energy; utilities, an oil company, a gas company. And then we have a big group of renewable energy companies." There's more exciting news...
Related Links: Energy Initiative website || EILC Article || CU Tech Transfer Channel || CU TTO || Keywords: Energy Initiative Leadership Council, EILC, Paul Nelson, Kate Tallman, CU TTO, Tech Transfer, Energy - Channel: CUTTO - Bytes: 13102919- 10/27/08 LISTEN
Return to TOC

555_ Economic Development Stimulated by Tech Transfer and BioScience
There are amazing stories coming out of CU Tech Trasfer Office and the BioScience sector in Colorado. HB1001 gives a five year pipeline of new Colorado bioscience companies with hundreds of new jobs in the industry as well as increased private capital invested in Colorado companies. With all this excitement, Larry interviewed three key players at Fitzsimons: David Allen, Associate Vice President Tech Transfer Office at the University of Colorado (CU TTO); Denise Brown Executive Director of the Colorado Bioscience Assoc (CBSA); and Dr. Richard Duke, is the chair of the CBSA’s Public Policy and Government Relations Committee, as well as President and CEO of Apoplogic Pharmaceuticals. Denise said, "The ideas for House Bill 1001 started several years ago, and inside the CBSA. We have a Public Affairs and Government Relations Committee and Richard Duke has been chair of the committee over the last five years, since its inception. It was really Rick and his colleagues sitting around that table where they began to define an agenda over several years to identify where we sat with the state, with higher education, to promote the growth of the industry and to accelerate the commercialization of the technologies out of our research and development institutions." Listen for more exciting details...
Related Links: CU TTO || Colorado BioScience Association || Apoplogic || Proof of Concept || BioScience Channel || Keywords: Dave Allen, Richard Duke, Denise Brown, CU TTO, Proof of Concept, Tech Transfer, HB1001, CBSA, Apoplogic > Bytes: 19764770 > LISTEN 9/22/08
Return to TOC

529_ Tech Transfer: The Challenges; Choices and the Champions Part 1 of 3
Every US research university is involved in inventive activity and technology transfer. Licensing new technology to innovative companies also creates significant economic development benefits. Larry has been following the University of Colorado Tech Transfer Office (TTO) for a few years and is extremely impressed with with their track record. This is a follow-up series that focuses on the 2007-08 Metrics Report and the interview includes the challenges, also. Four leaders from TTO shared their insights: Dave Allen, Associate VP for Technology Transfer; Kate Tallman, Director of Technology Transfer, Boulder and Colorado Springs Campuses; Tom Smerdon, Director Of Licensing & New Business Development; Rick Silva, Director of Technology Transfer, Anschutz Medical Campuses. They discussed the revenue challenges, disclosure rate, patent reimbursements, infrastructure building and more. Listen as this is significant information about the future of Colorado.
Related Links: 2007-08 Metrics Report || CU TTO Home || CU TTO Channel || PodCasting Directory || Keywords: Dave Allen, Kate Tallman, Tom Smerdon, Rick Silva, Tech Transfer, Anschutz Medical, TTO - Bytes: 16766331 LISTEN 7/28/08
Return to TOC

532_ Colorado Success Stories; Industry; Education; Government 2 of 3
In part 2 of this series about the 2007-08 Metrics Report at CU TTO, a number of success stories are highlighted. Listen and you'll hear about Sierra Neuropharma, Precision Biopsy, Tissue Genetics, ARCA, Apoplogic, Barofold, Copernican Energy and more. Four leaders from TTO continued to share their insights: Dave Allen, Associate VP for Technology Transfer; Kate Tallman, Director of Technology Transfer, Boulder and Colorado Springs Campuses; Tom Smerdon, Director Of Licensing & New Business Development; Rick Silva, Director of Technology Transfer, Anschutz Medical Campuses. The transformation into renewable energy economy is having a great impact on CU. There has been some interesting leadership involvement with the Collaboratory. The Collaboratory has been active in the last couple of years in bringing together several research centers among the four institutions (CU, CSU, Mines & NREL). CU TTO has also formed Over the past couple of years we’ve formed a strong relationship with the (BIC) the Boulder Innovation Center. Listen for more details...
Related Links: 2007-08 Metrics Report|| CU TTO Home || CU TTO Channel || Web Community Calendar || Keywords: Sierra Neuropharma, Precision Biopsy, Tissue Genetics, ARCA, Apoplogic, Barofold, Copernican Energy, Dave Allen, Kate Tallman, Tom Smerdon, Rick Silva, Tech Transfer, Boulder Innovation Center > Bytes: 13492039 LISTEN 8/4/08
Return to TOC

HB1001 Provides 3 Different Dimensions or Components of Funding 3 of 3
535_ "HB1001: Delighted that CBSA, the legislature and the governor’s office came together to pull an integrated program of bio science development and commercialization for Colorado. We have a 5 year funding, $5.5 mil/year and in almost all cases there will be matching funds, basically $11 million per year program for the next 5 years. It provides 3 different dimensions or components of funding. 1. Proof of concept funding. 2. Matching funding for companies (that’s any kind of non-founder matching. 3. A dimension to infrastructure as concerns University commercialization," said David Allen, Associate VP for Technology Transfer at the University of Colorado. David and leaders from TTO continued to share their insights Kate Tallman, Director of Technology Transfer, Boulder and Colorado Springs Campuses; Tom Smerdon, Director Of Licensing & New Business Development; Rick Silva, Director of Technology Transfer, Anschutz Medical Campuses. To be really successful at Tech Transfer, the organization that does it has to have 5 core competencies. The first is to develop relationships with the faculty such that the investigators will make disclosures to us, in that we can make judgments about a potential asset in that research. Second, Working to protect that intellectual property longer because maturation process is so long. But at the same time, if we get more proof of concept money the maturation period might not be so long. Third is leveraging. Fourth: is the whole notion of the technology maturation, relatively new for us, and we have to rely a lot on people outside. Fifth: The last, we do an exceptional job, compared to other universities.
Related Links: 2007-08 Metrics Report || CU TTO Home || CU TTO Channel || Find It || Keywords: Sierra Neuropharma, Precision Biopsy, Tissue Genetics, ARCA, Apoplogic, Barofold, Copernican Energy, Dave Allen, Kate Tallman, Tom Smerdon, Rick Silva, Tech Transfer, Boulder Innovation Center > Bytes: 16327892 LISTEN 8/11/08
Return to TOC

495_ Going From Proof of Concept Funding to $65 Mil in Series B Funding
Taligen Therapeutics, Inc. was founded in March 2004 to develop and commercialize technology developed by UC Denver’s Dr. V. Michael Holers for the treatment of serious inflammatory disease. Larry talked with Dr. Holers and Dr. Woodruff Emlen, MD co-founder, President, CEO and Director of Taligen. Taligen received its initial impetus through receipt of the inaugural grant in CU TTO’s Proof of Concept Grant (POCg) Program in 2004 and subsequently, SBIR grants. In August 2005 Taligen received its Series A financing of $3.75M led by Sanderling Ventures, Tango and High Country Venture. On Feb. 1, 2008 the company announced the closing of a $65M Series B financing. Formerly, Dr. Emlen [was at the University of Colorado] and Dr. Holers are a wonderful example of how industry and the academic world can team up to build a business that will benfit humanity. They both appreciate the work and support they get from CU TTO. Taligen is developing technologies to manipulate complement proteins of the immune system to inhibit inflammation and to target inhibitors of inflammation to specific sites of tissue injury; the initial disease targets are macular degeneration and asthma.
Related Links: Taligen Therapeutics || CU Tech Transfer Offices || CU TTO Channel || Find It || Keywords: Michael Holers, Woodruff Emlen, Taligen Therapeutics, Macular Degeneration, Asthma, CU Tech Transfer - Bytes: 11510912 - 5/26/08
Return to TOC

472_ Collaboratory, C2B2, Center for Revolutionary Solar Photo Conversion Part 1 of 2
“Who would have thought, just a couple of years ago, that you could get three universities and a national lab working together? Not only cooperating but enjoying the process,” said David Hiller, Executive Director of the Colorado Renewable Energy Collaboratory. Larry interviewed David Hiller and Carl Koval at the CU Tech Transfer Office in Boulder. On April 21st at the Capital building in Denver, three Colorado universities, Colorado State University, Colorado School of Mines and University of Colorado at Boulder and NREL together with a number of industrial partners will announce the formation of "The Center for Revolutionary Solar Photo Conversion". The main purpose will be to discover and develop 3rd generation solar photo conversion,” announced Carl Koval, Professor at CU Boulder in the Dept. of Chem. and Bio-chem. He also serves as the CU institutional coordinator for the Collaboratory and also the faculty director for CU Boulder’s Renewable and Sustainable Energy Initiative. They went into detail about the Collaboratory which is a major collaboration in the area of bio fuels and bio refining as well as C2B2 (the Colorado Center for Bio Fuels and Bio Refining) which has 28 industrial partners. There's much more...
Related Links: Collaboratory || C2B2 || CU TTO Channel || CU TTO || BYTES: 23543121 - 4/14/08 > Keywords: David Hiller, Carl Koval, CU Tech Transfer, Collaboratory, C2B2, Center for Revolutionary Solar Photo Conversion
Return to TOC

475_ Colorado: The Silicon Valley of Renewable Energy Part 2 of 2
(Part 2 of 2) ConocoPhillips purchased the old Storage Tek site in Louisville, and their current plan is to create a 5000 to 10,000 person research and training center related primarily to their interest in renewable and alternative energy. They’re doing that here in Colorado, but they’re not the only one setting up offices here! David Hiller, Executive Director of the Colorado Renewable Energy Collaboratory and Carl Koval, Professor at CU Boulder in the Dept. of Chemistry and Bio-chem (and he also serves as the CU institutional coordinator for the Collaboratory; and also the faculty director for CU Boulder’s Renewable and Sustainable Energy Initiative) discuss the growth of the this past year. A year ago when we were starting the Collaboratory we used this phrase, kind of tongue in cheek – “Colorado the Silicon Valley of Renewable Energy”. But it’s no longer tongue in cheek. These companies are not only investing in research, they’re moving here. They range from Fortune 50 companies to very large international energy companies such as ConocoPhillips, Chevron, Shell, DuPont and more... In addition, there is a great deal of interest from the private sector.
Related Links: Collaboratory || C2B2 || CU TTO Channel || Tech Transfer Office || Keywords: David Hiller, Carl Koval, CU Tech Transfer, Collaboratory, C2B2, ConocoPhillips, Chevron, Shell, DuPont - Bytes: 19941149 - 4/21/08
Return to TOC

454_ Two Young Girls Meet as Adults to Improve Cancer Treatments
Earlier this year, Dr. Lia Gore, Assistant Prof of Pediatrics & Medical Oncology and Dr. Deborah DeRyckere, Center for Cancer and Blood, were given the New Inventors of the Year award for UC Denver (Anschutz Medical Campus) by the University of Colorado Tech Transfer Office (CU TTO). The award was based on work that Dr. Gore and Dr DeRyckere started almost four years ago, thinking about new ways to develop treatments for cancer. Not only new ways, but thinking about treatments that have been around for awhile but not necessarily been used together. They were approached by the Tech Transfer Office, who said, this is really a pretty interesting idea and asked them if they thought about a patent? Have you thought about the fact that this is a very different way of thinking about these things?
     Dr. Gore said, " Being in science and medicine, of course we hadn’t, because we don’t think that way." It was very enlightening to get input from people who think about technology and technology advancement, because that is not what their skills and strengths are. So it has evolved over time. Larry asked both Deb and Lia what was it, in their earlier life that got them involved in the medical arena. You parents might want to share this interview with your children. They went onto say, "It’s a huge motivating factor when we think we can improve the quality of someone’s life. Not only by treating the cancer effectively but by making the therapy more tolerable, less toxic and help somebody live through that therapy better than they have in the past. It’s a pretty remarkable privilege to think about doing that." There's more...  
Related Links: CU Tech Transfer Office || CU TTO Channel || UCDHSC || Podcast Directory ||   Keywords: Lia Gore, Deborah DeRyckere, Tech Transfer, CUTTO, Cancer Treatment, Fitzsimons, UCDHSC, Bytes: 21809426 > 3/10/08 Return to TOC